Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss of $1.87/Share

August 10, 2016 5:27 PM

Eiger BioPharmaceuticals (NASDAQ: EIGR) reported Q2 EPS of ($1.87), versus ($13.34) reported last year.

For earnings history and earnings-related data on Eiger BioPharmaceuticals (EIGR) click here.

Categories

Earnings

Next Articles